Evidence map›Paper›PMID 31353796›Full record

ArticleMolecular systems biology2019

Systems approach reveals photosensitivity and PER2 level as determinants of clock-modulator efficacy.

Dae Wook Kim, Cheng Chang, Xian Chen, Angela C Doran, Francois Gaudreault, Travis Wager, George J DeMarco, Jae Kyoung Kim

Open access · goldAbstract read
In one paragraph

Article in Molecular systems biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Phosphorylation of DNA-binding domains of CLOCK-BMAL1 complex for PER-dependent inhibition in circadian clock of mammalian cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. The circadian clock of the bacteriumScience advances · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Dae Wook KimDepartment of Mathematical Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea.ORCID 0000-0003-1060-891X
Cheng ChangClinical Pharmacology, Pfizer Global Product Development, Pfizer Inc., Groton, CT, USA.ORCID 0000-0002-8189-9921
Xian ChenComparative Medicine, Worldwide Research & Development, Pfizer Inc., Cambridge, MA, USA.
Angela C DoranEnzymology and Transporter Group, Pharmacokinetics, Dynamics and Metabolism, Worldwide Research & Development, Pfizer Inc., Groton, CT, USA.
Francois GaudreaultClinical Pharmacology and Pharmacometrics, Research & Development, Biogen Inc., Cambridge, MA, USA.
Travis WagerNeuroscience Research Unit, Worldwide Research & Development, Pfizer Inc., Boston, MA, USA.
George J DeMarcoDepartment of Animal Medicine, University of Massachusetts Medical School, Worcester, MA, USA.
Jae Kyoung KimDepartment of Mathematical Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea.ORCID 0000-0001-7842-2172
Pfizer (United States) · USKorea Advanced Institute of Science and Technology · KRBiogen (United States) · USUniversity of Massachusetts Chan Medical School · US

Funding

Human Frontiers Science Program Organization RGY0063/2017Korea Advanced Institute of Science and TechnologyNational Research Foundation of Korea NRF-2016 RICIB 3008468National Research Foundation of Korea NRF-2017-Fostering Core Leaders of the Future Basic Science Program/Global Ph.D. Fellowship ProgramPfizer G01160179
6 · The paper itself

Abstract

In mammals, the master circadian clock synchronizes daily rhythms of physiology and behavior with the day-night cycle. Failure of synchrony, which increases the risk for numerous chronic diseases, can be treated by phase adjustment of the circadian clock pharmacologically, for example, with melatonin, or a CK1δ/ε inhibitor. Here, using in silico experiments with a systems pharmacology model describing molecular interactions, and pharmacokinetic and behavioral experiments in cynomolgus monkeys, we find that the circadian phase delay caused by CK1δ/ε inhibition is more strongly attenuated by light in diurnal monkeys and humans than in nocturnal mice, which are common preclinical models. Furthermore, the effect of CK1δ/ε inhibition strongly depends on endogenous PER2 protein levels, which differs depending on both the molecular cause of the circadian disruption and the patient's lighting environment. To circumvent such large interindividual variations, we developed an adaptive chronotherapeutics to identify precise dosing regimens that could restore normal circadian phase under different conditions. Our results reveal the importance of photosensitivity in the clinical efficacy of clock-modulating drugs, and enable precision medicine for circadian disruption.

Indexed as

AnimalsCasein Kinase IdeltaCircadian ClocksCircadian RhythmCryptochromesDrug Administration ScheduleDrug ChronotherapyGene Expression RegulationHumansLightLight Signal TransductionMacaca fascicularisMicePeriod Circadian ProteinsPhotoperiodPrecision MedicineCasein Kinase IdeltaCRY1 protein, humanCRY2 protein, humanCryptochromesPER2 protein, humanPeriod Circadian ProteinsPF-670462Protein Kinase InhibitorsPyrimidinescircadian rhythmsCK1δ/ε inhibitorpersonalized chronotherapysystems pharmacology model

Identifiers

PMID31353796
PMCPMC6613017
OpenAlexW2955140778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.